La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

PhytoHealth Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

I-Lin Lee

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	3.2yrs
Proprietà del CEO	n/a
Durata media del management	3.4yrs
Durata media del Consiglio di amministrazione	4.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

PhytoHealth (TPE:4108) Is In A Good Position To Deliver On Growth Plans

Mar 01

The PhytoHealth (TPE:4108) Share Price Has Gained 60% And Shareholders Are Hoping For More

Jan 07

AMMINISTRATORE DELEGATO

I-Lin Lee

3.2yrs

Mandato

I-Lin Lee serves as Director at PhytoHealth Corporation since May 26, 2020 and serves as its President since August 4, 2021. I-Lin Lee experience includes PhytoHealth Corporation AmCad BioMed Corporation L...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Yi-Li Lee	Chairman	4.2yrs	NT$2.45m	0.15% NT$ 5.4m
I-Lin Lee	President & Director	3.2yrs	Nessun dato	Nessun dato
Chih Yuan Huang	Financial & Accounting Officer	3.4yrs	Nessun dato	Nessun dato
Kevin Lin	Manager of Administration Division	no data	Nessun dato	Nessun dato
Fred Lai	Managing Director	no data	Nessun dato	Nessun dato
Li Feng Yeh	Chief Internal Officer	3.4yrs	Nessun dato	Nessun dato

3.4yrs

Durata media

Gestione esperta: Il team dirigenziale di 4108 è considerato esperto (durata media dell'incarico 3.3 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Yi-Li Lee	Chairman	4.2yrs	NT$2.45m	0.15% NT$ 5.4m
I-Lin Lee	President & Director	4.4yrs	Nessun dato	Nessun dato
Chen-Chia Lee	Director	no data	Nessun dato	0.15% NT$ 5.4m
Der Shan Wang	Independent Director	no data	NT$290.00k	Nessun dato
Sun-Quae Lai	Independent Director	no data	NT$275.00k	Nessun dato
Yu-Ju Lai	Director	4.4yrs	NT$260.00k	Nessun dato
Ming-Fu Wang	Director	4.4yrs	NT$260.00k	Nessun dato
Shoei-Loong Lin	Independent Director	4.4yrs	NT$290.00k	Nessun dato
Tse-Hung Huang	Director	4.4yrs	NT$260.00k	Nessun dato
Ching-Chung Tsai	Director	4.4yrs	NT$260.00k	0.00086% NT$ 30.8k
Yang-Chang Wu	Independent Director	1.4yrs	Nessun dato	Nessun dato
Pai-Sen Wang	Director	1.4yrs	NT$255.00k	Nessun dato

4.4yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 4108 sono considerati esperti (durata media dell'incarico 4.3 anni).

PhytoHealth Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

PhytoHealth Corporation, Annual General Meeting, May 28, 2024

PhytoHealth Corporation Announces the Resignation of Chen Wen-Hwa as Legal Representative and Director

PhytoHealth Corporation Elects Wang Pai-Sen as a Director

PhytoHealth Corporation Appoints Wu Yang-Chang as Independent Director

PhytoHealth Corporation, Annual General Meeting, May 24, 2022

Recent updates

Second quarter 2024 earnings released: NT$0.08 loss per share (vs NT$0.076 loss in 2Q 2023)

PhytoHealth Corporation to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: NT$0.14 loss per share (vs NT$0.037 loss in 1Q 2023)

PhytoHealth Corporation to Report Q1, 2024 Results on May 03, 2024

Full year 2023 earnings released: NT$0.24 loss per share (vs NT$0.40 loss in FY 2022)

PhytoHealth Corporation, Annual General Meeting, May 28, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: NT$0.037 (vs NT$0.02 in 3Q 2022)

New minor risk - Share price stability

PhytoHealth Corporation Announces the Resignation of Chen Wen-Hwa as Legal Representative and Director

Second quarter 2023 earnings released: NT$0.07 loss per share (vs NT$0.092 loss in 2Q 2022)

PhytoHealth Corporation Elects Wang Pai-Sen as a Director

PhytoHealth Corporation Appoints Wu Yang-Chang as Independent Director

Full year 2022 earnings released: NT$0.40 loss per share (vs NT$0.40 loss in FY 2021)

Second quarter 2022 earnings released: NT$0.10 loss per share (vs NT$0.13 loss in 2Q 2021)

First quarter 2022 earnings released: NT$0.14 loss per share (vs NT$0.14 loss in 1Q 2021)

PhytoHealth Corporation Announces R&D Progress of the One New Drugs Currently in Development

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

PhytoHealth Corporation, Annual General Meeting, May 24, 2022

Third quarter 2021 earnings released: EPS NT$0.04 (vs NT$0.18 loss in 3Q 2020)

Director & President Chien-Hsin Cheng has left the company

Second quarter 2021 earnings released: NT$0.13 loss per share (vs NT$0.018 profit in 2Q 2020)

First quarter 2021 earnings released: NT$0.14 loss per share (vs NT$0.22 loss in 1Q 2020)

PhytoHealth (TPE:4108) Is In A Good Position To Deliver On Growth Plans

Full year 2020 earnings released: NT$0.54 loss per share (vs NT$1.04 loss in FY 2019)

Phytohealth Corporation Announces Current R&D Progress on PG2, Anti-Osteoporosis, and Moderate to Severe Pain Relief New Drugs

New 90-day high: NT$30.80

The PhytoHealth (TPE:4108) Share Price Has Gained 60% And Shareholders Are Hoping For More

New 90-day high: NT$28.10

New 90-day low: NT$23.35

New 90-day low: NT$23.40

Third quarter 2020 earnings released: NT$0.18 loss per share

New 90-day low: NT$24.70

New 90-day low: NT$25.15

New 90-day low: NT$26.70

First half earnings released

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media